gnta does show that relying on big pharma validation is no guarantee. ave wasted a lot of $ on them. Another "validated" company, cgtk blew up today as apparently the decoy was just that Bristol will surely walk if their cabg graft trial fails (very high probability imo). Todays data seemed to indicate the decoy did absolutely nothing, a complete whiff.